Sptlc2 deficiency did not impact splenocyte or tumor-infiltrating leukocyte numbers (Supplementary Fig. 7f) but increased the tumor growth longitudinally and the tumor weight at the endpoint (Fig. 7c, d). Here, SPTLC2 is linked to neoplasm.